Professor Shulin Li, Editor-in-Chief

Shulin Li is currently a Professor in the Department of Pediatrics at The University of Texas MD Anderson Cancer Center, U.S.A. He became Assistant Professor in 1999 at the Department of Otolaryngology, University of Arkansas, for Medical Sciences. Following this, he held the position of Professor of the Louisiana State University School of Veterinary Medicine’s Department of Comparative Biomedical Sciences. Professor Li has received several honors and awards over the years, including being awarded the Pfizer Award for Research Excellence (2005), being selected as Charter Member of Developmental Therapeutics Study Section for the National Institute of Health (NIH) (2008), and serving as Chair of Physical Gene Therapy & Vectorology Committee of the American Society of Gene and Cell Therapy (ASGCT) (2009-2011). Professor Li’s research interests include gene delivery and gene therapy, tumor and host cell communication, as well as immune therapy and cytokines.